Skip to content

Exploring the role of Lasunadaya Ghrita pana and nasya in primary depression:A non randomized open clinical study.

"Exploring the role of Lasunadya Ghrita Pana & Nasya in case of Primary Depression:A non randomized open clinical study". - LGPD

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020756
Enrollment
72
Registered
2019-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F321- Major depressive disorder, singleepisode, moderate Health Condition 2: null- primary depression

Interventions

Intervention1: LASUNADYA GHRITA: DOSE- 5 gram in two divided doses with warm milk Duration: 28 days Route of administration: Oral & Nasal Instillation. Control Intervention1: ESCITALOPRAM: Dose:- 10m

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed as primary depression as per ICD-10 criteria.patient having depression for not more than two years.patients willing to participate in the study voluntarily giving their informed consent.patient not having any other physical and mental co-morbidity considered as contraindication to the treatment.

Exclusion criteria

Exclusion criteria: Patient below 20 years and over 60 years.Patients having any other psychiatric co-morbidity.Patient having cognitive malfunctions due to substance abuse or due to age related dementia or mental retardation.Females in the stage of pregnancy or lactation.Patients having suicidal ideation or history of attempted suicide.Patients with marked irritable,unstable and violent behaviour.Patients allergic to any component of medication.Patients unable to take lasun or go-mutra due to their personal customs or belief.Patients not giving the consent for the study.Any condition where nasya is contraindicated.

Design outcomes

Primary

MeasureTime frame
Improvement in Hamilton Depression ScaleTimepoint: Base line and 4 week

Secondary

MeasureTime frame
SF-36Timepoint: Base line and Week 4

Countries

India

Contacts

Public Contactvandana tiwari

STATE AYURVEDIC COLLEGE LUCKNOW

rastogisanjeev@rediffmail.com9415022955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026